Skip to main content

Lamotrigine

NDC 70771-1518 · Zydus Lifesciences Limited

Generic nameLamotirigine
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)LAMOTRIGINE
Strength250 mg/1
Pharmacologic classAnti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]
Marketing categoryANDA

Packages

70771-1518-3 — 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1518-3)

70771-1518-4 — 10 BLISTER PACK in 1 CARTON (70771-1518-4) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70771-1518-2)

70771-1518-5 — 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1518-5)

70771-1518-9 — 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1518-9)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70518-2889 — LAMOTRIGINE, 70518-3043 — Lamotrigine, 70518-4121 — Lamotrigine, 70518-4442 — lamotrigine extended-release, 70518-4638 — lamotrigine extended-release, 70518-4702 — Lamotrigine, 70771-1514 — Lamotirigine, 70771-1515 — Lamotirigine, 70771-1516 — Lamotirigine, 70771-1517 — Lamotirigine, 70771-1519 — Lamotirigine, 71205-245 — Lamotrigine, 71335-0706 — Lamotrigine, 71335-0830 — Lamotrigine, 71335-1110 — Lamotrigine, 71335-1179 — Lamotrigine, 71335-1469 — Lamotrigine, 71335-1919 — Lamotrigine, 71335-2071 — Lamotrigine, 71335-2328 — Lamotrigine, +270 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.